Novartis Calls for FDA Enforcement Against Biosimilar Misinformation

Novartis Calls for FDA Enforcement Against Biosimilar Misinformation

Source: 
RAPS.org
snippet: 

Building off a Pfizer citizen petition on biosimilar misinformation, Novartis is calling on FDA to set the record straight on what information can be disseminated.